BRD4: New hope in the battle against glioblastoma
Authors:
Open Access
- 13 April 2023
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 191, 106767
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82102846)
This publication has 164 references indexed in Scilit:
- Small-Molecule Inhibition of BRDT for Male ContraceptionCell, 2012
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- Regulation of chromatin by histone modificationsCell Research, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Bromodomain 4 activation predicts breast cancer survivalProceedings of the National Academy of Sciences, 2008
- Histone acetyltransferase complexes: one size doesn't fit allNature Reviews Molecular Cell Biology, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Epidemiology and etiology of gliomasActa Neuropathologica, 2005
- The history of cancer epigeneticsNature Reviews Cancer, 2004